Westwood Management Corporation’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,866
Closed -$239K 71
2023
Q1
$239K Hold
5,866
0.03% 65
2022
Q4
$301K Hold
5,866
0.04% 58
2022
Q3
$257K Hold
5,866
0.03% 64
2022
Q2
$308K Hold
5,866
0.04% 59
2022
Q1
$304K Hold
5,866
0.03% 64
2021
Q4
$346K Hold
5,866
0.03% 65
2021
Q3
$252K Hold
5,866
0.02% 71
2021
Q2
$230K Hold
5,866
0.02% 76
2021
Q1
$213K Hold
5,866
0.02% 77
2020
Q4
$216K Buy
+5,866
New +$215K 0.02% 72

Other funds holding PFE

Westwood Management Corporation's PFE Position: Q2 2023 in Review

Westwood Management Corporation sold out of Pfizer (PFE) in Q2 2023, closing a stake of 5,866 shares — an estimated $239K sold.

Westwood Management Corporation first reported a position in PFE in Q4 2020 and held it in 10 quarters. The position peaked at $346K in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • Westwood Management Corporation reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
  • Westwood Management Corporation sold 5,866 Pfizer shares in Q2 2023, an estimated $239K.
  • Westwood Management Corporation first reported a position in Pfizer in Q4 2020 and held it in 10 quarters.
  • Westwood Management Corporation's Pfizer position peaked at $346K in Q4 2021.
  • 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Westwood Management Corporation's 13F filing for Q2 2023, filed 26 Jul 2023.